News

November 11, 2025

Odyssey Therapeutics Appoints Dennis Dean, Ph.D., as Executive Vice President, Head of Non-Clinical Development

October 22, 2025

The Evolution of Themed Slot Games: A Case Study on Aloha Party

October 9, 2025

Odyssey Therapeutics Appoints Pharmaceutical Leader Nia Tatsis, Ph.D., to its Board of Directors      

September 10, 2025

Odyssey Therapeutics Announces Oversubscribed $213 Million Series D Financing to Advance Clinical Pipeline for Autoimmune Diseases

January 8, 2025

Odyssey Therapeutics Appoints Jason Haas as Chief Financial Officer